Last reviewed · How we verify
ziprasidone vs risperidone or olanzapine — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
ziprasidone vs risperidone or olanzapine (ziprasidone vs risperidone or olanzapine) — Northwell Health.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| ziprasidone vs risperidone or olanzapine TARGET | ziprasidone vs risperidone or olanzapine | Northwell Health | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- ziprasidone vs risperidone or olanzapine CI watch — RSS
- ziprasidone vs risperidone or olanzapine CI watch — Atom
- ziprasidone vs risperidone or olanzapine CI watch — JSON
- ziprasidone vs risperidone or olanzapine alone — RSS
Cite this brief
Drug Landscape (2026). ziprasidone vs risperidone or olanzapine — Competitive Intelligence Brief. https://druglandscape.com/ci/ziprasidone-vs-risperidone-or-olanzapine. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing